- Home
- PSNL vs NX Comparison
PSNL vs NX Comparison
Compare PSNL & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PSNL | NX |
|---|---|---|
| Founded | 2011 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 729.1M | 797.0M |
| IPO Year | 2019 | 2008 |
Fundamental Metrics
Financial Performance| Metric | PSNL | NX |
|---|---|---|
| Price | $6.72 | $16.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $11.50 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 1.3M | 538.3K |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 1.88% |
| EPS Growth | ★ 33.58 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $69,648,000.00 | ★ $1,837,641,000.00 |
| Revenue This Year | $16.94 | $3.18 |
| Revenue Next Year | $36.58 | $2.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 43.81 |
| 52 Week Low | $2.83 | $11.04 |
| 52 Week High | $11.50 | $22.90 |
Technical Indicators
Market Signals| Indicator | PSNL | NX |
|---|---|---|
| Relative Strength Index (RSI) | 34.61 | 29.49 |
| Support Level | $4.31 | $16.09 |
| Resistance Level | $6.94 | $20.08 |
| Average True Range (ATR) | 0.71 | 0.84 |
| MACD | -0.19 | -0.52 |
| Stochastic Oscillator | 5.95 | 4.41 |
Price Performance
Historical ComparisonAbout PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About NX Quanex Building Products Corporation
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.